Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BMS-986094
BMS-986094
Hepatitis C In Play for 2013?
Motley Fool
Wed, 02/27/13 - 11:24 am
hepatitis C
BMS-986094
Bristol-Myers Squibb
Gilead
Idenix
Incivek
Achillion
Vertex Pharmaceuticals
5 Drug Hopefuls That Are Going to Change Your Life: Part 2
Motley Fool
Sat, 11/24/12 - 12:01 pm
Gilead Sciences
sofosbuvir
hepatitis C
Bristol-Myers Squibb
BMS-986094
Idenix
IDX-184
Abbott Laboratories
Achillion
ACH-3102
Idenix: Is This Hepatitis-C Company a Bargain or a Bust?
Motley Fool
Wed, 10/10/12 - 12:39 pm
Idenix
hepatitis C
BMS-986094
Bristol-Myers Squibb
The Most Epic Drug Failure. Ever.
Motley Fool
Sat, 08/25/12 - 11:24 am
Bristol-Myers Squibb
BMS-986094
hepatitis C
Bristol to take $1.8 billion charge on hepatitis C drug failure
Reuters
Fri, 08/24/12 - 10:33 am
Bristol-Myers Squibb
hepatitis C
BMS-986094
Pipeline Setback at Bristol-Myers
Yahoo/Zacks
Sat, 08/4/12 - 12:14 pm
Bristol-Myers Squibb
BMS-986094
hepatitis C
INX-189
Bristol-Myers: hepatitis C drug trial hit by safety issue
Reuters
Thu, 08/2/12 - 10:19 am
Bristol-Myers Squibb
hepatitis C
BMS-986094